Doximity (DOCS) closed the most recent trading day at $21.52, moving -3.11% from the previous trading session. This change lagged the S&P 500's 1.01% loss on the day. Elsewhere, the Dow saw a downswing of 0.77%, while the tech-heavy Nasdaq depreciated by 1.4%.
The medical social networking site's stock has climbed by 8.55% in the past month, exceeding the Medical sector's gain of 5.37% and the S&P 500's gain of 0.32%.
The investment community will be paying close attention to the earnings performance of Doximity in its upcoming release. The company is slated to reveal its earnings on August 6, 2026. In that report, analysts expect Doximity to post earnings of $0.29 per share. This would mark a year-over-year decline of 19.44%. Meanwhile, the latest consensus estimate predicts the revenue to be $151.7 million, indicating a 3.97% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $1.39 per share and revenue of $670.18 million, which would represent changes of -8.55% and +3.93%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Doximity. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Doximity is currently a Zacks Rank #3 (Hold).
In the context of valuation, Doximity is at present trading with a Forward P/E ratio of 15.93. This valuation marks a discount compared to its industry average Forward P/E of 27.82.
Meanwhile, DOCS's PEG ratio is currently 4.15. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 3.15.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 74, this industry ranks in the top 31% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow DOCS in the coming trading sessions, be sure to utilize Zacks.com.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Doximity, Inc. (DOCS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).